Comprehensive mutation screening in a cystic fibrosis center

被引:19
作者
Wine, JJ
Kuo, E
Hurlock, G
Moss, RB
机构
[1] Stanford Univ, Sch Med, Dept Pediat, Div Pulm, Palo Alto, CA 94304 USA
[2] Stanford Univ, Cyst Fibrosis Res Lab, Palo Alto, CA 94304 USA
关键词
CFTR; alleles; SSCP; heteroduplex analysis;
D O I
10.1542/peds.107.2.280
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objectives and Background. The identities of a cystic fibrosis (CF) patient's CFTR mutations can influence therapeutic strategies, but because >800 CFTR mutations exist, cost-effective, comprehensive screening requires a multistage approach. Single-strand conformation polymorphism and heteroduplex analysis (SSCP/HA) can be an important part of mutation detection, but must be calibrated within each laboratory. The sensitivity of a combined commercial-SSCP/HA approach to genotyping in a large, ethnically diverse US center CF population has not been established. Study Design. We screened all 27 CFTR exons in 10 human participants who had an unequivocal CF diagnosis including a positive sweat chloride test and at least 1 unknown allele after commercial testing for the 70 most common mutations by SSCP/HA. These participants were compared with 7 participants who had negative sweat tests but at least 1 other CF-like symptom meriting complete genotyping. Results. For the 10 CF participants, we detected 11 of 16 unknown alleles (69%) and all 4 of the known alleles (100%), for an overall rate of 75% inpatients not fully genotyped by conventional 70 mutation screen. For 7 participants with negative sweat tests, we confirmed 1 identified mutation in 14 alleles and detected 3 additional mutations. Mutations detected in both groups included 7 missense mutations (S13F, P67L, G98R, S492F, G970D, L1093P, N1303K) and 9 deletion, frameshift, nonsense or splicing mutations (R75X, G542X, Delta F508, 451-458 Delta8 bp, 5T, 663 DeltaT, exon 13 frameshift, 1261+1G-->A and 3272-26A-->G). Three of these mutations were novel (G970D, L1093P, and 451-458 Delta8 bp(1)). Thirteen other changes were detected, including the novel changes 1812-3 ins T, 4096-278 ins T, 4096-265 ins TG, and 4096-180 T-->G. Conclusion. When combined with the 70 mutation Genzyme test, SSCP/HA analysis allows for detection of >95% of the mutations in an ethnically heterogeneous CF center population. We discuss 5 possible explanations that could account for the few remaining undetected mutations.
引用
收藏
页码:280 / 286
页数:7
相关论文
共 32 条
[1]   IDENTIFICATION OF 12 NOVEL MUTATIONS IN THE CFTR GENE [J].
AUDREZET, MP ;
MERCIER, B ;
GUILLERMIT, H ;
QUERE, I ;
VERLINGUE, C ;
RAULT, G ;
FEREC, C .
HUMAN MOLECULAR GENETICS, 1993, 2 (01) :51-54
[2]   Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line [J].
Bedwell, DM ;
Kaenjak, A ;
Benos, DJ ;
Bebok, Z ;
Bubien, JK ;
Hong, J ;
Tousson, A ;
Clancy, JP ;
Sorscher, EJ .
NATURE MEDICINE, 1997, 3 (11) :1280-1284
[3]   Complete mutational screening of the CFTR gene in 120 patients with pulmonary disease [J].
Bombieri, C ;
Benetazzo, M ;
Saccomani, A ;
Belpinati, F ;
Gilè, LS ;
Luisetti, M ;
Pignatti, PF .
HUMAN GENETICS, 1998, 103 (06) :718-722
[4]   Strategies for correcting the ΔF508 CFTR protein-folding defect [J].
Brown, CR ;
Hong-Brown, LQ ;
Welch, WJ .
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 1997, 29 (05) :491-502
[5]   DEFECTIVE INTRACELLULAR-TRANSPORT AND PROCESSING OF CFTR IS THE MOLECULAR-BASIS OF MOST CYSTIC-FIBROSIS [J].
CHENG, SH ;
GREGORY, RJ ;
MARSHALL, J ;
PAUL, S ;
SOUZA, DW ;
WHITE, GA ;
ORIORDAN, CR ;
SMITH, AE .
CELL, 1990, 63 (04) :827-834
[6]  
CHILLON M, 1995, AM J HUM GENET, V56, P623
[7]   Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes - The polymorphic (TG)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation [J].
Cuppens, H ;
Lin, W ;
Jaspers, M ;
Costes, B ;
Teng, H ;
Vankeerberghen, A ;
Jorissen, M ;
Droogmans, G ;
Reynaert, I ;
Goossens, M ;
Nilius, B ;
Cassiman, JJ .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :487-496
[8]   PROCESSING OF MUTANT CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR IS TEMPERATURE-SENSITIVE [J].
DENNING, GM ;
ANDERSON, MP ;
AMARA, JF ;
MARSHALL, J ;
SMITH, AE ;
WELSH, MJ .
NATURE, 1992, 358 (6389) :761-764
[9]   A NOVEL MUTATION IN THE CYSTIC-FIBROSIS GENE IN PATIENTS WITH PULMONARY-DISEASE BUT NORMAL SWEAT CHLORIDE CONCENTRATIONS [J].
HIGHSMITH, WE ;
BURCH, LH ;
ZHOU, ZQ ;
OLSEN, JC ;
BOAT, TE ;
SPOCK, A ;
GORVOY, JD ;
QUITTELL, L ;
FRIEDMAN, KJ ;
SILVERMAN, LM ;
BOUCHER, RC ;
KNOWLES, MR .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (15) :974-980
[10]   Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations [J].
Howard, M ;
Frizzell, DM ;
Bedwell, DM .
NATURE MEDICINE, 1996, 2 (04) :467-469